Burcon Nutrascience Corporation
BU.TO
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1,893.62% | 1,107.74% | 773.06% | 43.03% | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1,893.62% | 1,107.74% | 773.06% | 43.03% | -- |
| Cost of Revenue | 507.44% | 714.81% | 1,202.98% | 727.92% | -- |
| Gross Profit | -399.74% | -607.99% | -1,348.63% | -5,924.72% | -- |
| SG&A Expenses | -12.24% | -21.32% | -17.29% | -35.67% | -27.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 116.41% | 84.46% | 43.82% | 39.35% | 2.37% |
| Operating Income | -77.25% | -49.37% | -30.40% | -38.86% | -0.16% |
| Income Before Tax | -82.46% | -101.25% | -51.09% | -83.86% | -2.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -64.63% | -101.25% | -51.09% | -83.86% | -2.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -64.63% | -101.25% | -51.09% | -83.86% | -2.44% |
| EBIT | -77.25% | -49.37% | -30.40% | -38.86% | -0.16% |
| EBITDA | -23.87% | 6.42% | -32.33% | -40.56% | -0.85% |
| EPS Basic | -26.24% | -13.09% | 15.36% | -2.96% | 34.33% |
| Normalized Basic EPS | -39.98% | -13.07% | 15.35% | -2.91% | 34.34% |
| EPS Diluted | -26.24% | -13.09% | 15.36% | -2.96% | 34.33% |
| Normalized Diluted EPS | -39.98% | -13.07% | 15.35% | -2.91% | 34.34% |
| Average Basic Shares Outstanding | 30.43% | 77.94% | 78.49% | 78.59% | 55.99% |
| Average Diluted Shares Outstanding | 30.43% | 77.94% | 78.49% | 78.59% | 55.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |